Status:
RECRUITING
The LungVision Navigational Platform for Preoperative Labeling of Pulmonary Ground Glass Nodules With Fiducial Markers
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Based on current evidence, there are no studies investigating the possibility of placing a fiducial marker using augmented fluoroscopy, particularly for partially solid lesions that are often not visi...
Detailed Description
Lung cancer is the leading cause of cancer-related deaths, accounting for 1.8 million deaths in 2020. For this reason, early screening, diagnosis and treatment play a crucial role in improving the sur...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Evidence of a partially solid peripheral pulmonary nodule with a solid component ≥ 6 mm or increasing in size, even if smaller, with a bronchus sign or adjacent bronchus on chest CT;
- Obtaining the patient's informed consent.
Exclusion
- Pregnancy or suspected pregnancy;
- Contraindication to performing bronchoscopy under deep sedation, based on the anesthesiologist's assessment;
- Patient not eligible for surgery due to high surgical risk, based on the anesthesiologist's assessment.
Key Trial Info
Start Date :
July 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT07180823
Start Date
July 21 2025
End Date
February 28 2026
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138